Video

Molecular Devices Bio-Expo Live 2024: Quality, Data, & Analytical Solutions

This content is brought to you by Molecular Devices, a Danaher Operating Company.

3D in vitro models - including human organoids - represent a paradigm shift in drug discovery due to their superior physiological relevance and their ability to more faithfully predict patient response compared to the current standard of 2D cell line models. However, working with more complex models brings a unique set of challenges which must be overcome to ensure consistency, robustness and ease of use in drug discovery assays. This presentation discusses the ways in which Molecular Devices is overcoming these hurdles using innovative technologies to enable high-throughput, robust screens using these powerful cell models.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online